JP2024501284A5 - - Google Patents
Info
- Publication number
- JP2024501284A5 JP2024501284A5 JP2023538718A JP2023538718A JP2024501284A5 JP 2024501284 A5 JP2024501284 A5 JP 2024501284A5 JP 2023538718 A JP2023538718 A JP 2023538718A JP 2023538718 A JP2023538718 A JP 2023538718A JP 2024501284 A5 JP2024501284 A5 JP 2024501284A5
- Authority
- JP
- Japan
- Prior art keywords
- promoter
- composition according
- nonviral
- phagocytic
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063130105P | 2020-12-23 | 2020-12-23 | |
| US63/130,105 | 2020-12-23 | ||
| PCT/US2021/073084 WO2022140788A1 (en) | 2020-12-23 | 2021-12-22 | Methods of enhancing non-viral gene therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024501284A JP2024501284A (ja) | 2024-01-11 |
| JP2024501284A5 true JP2024501284A5 (https=) | 2024-12-20 |
Family
ID=82158434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023538718A Pending JP2024501284A (ja) | 2020-12-23 | 2021-12-22 | 非ウイルス遺伝子治療を強化する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240074986A1 (https=) |
| EP (1) | EP4267253A4 (https=) |
| JP (1) | JP2024501284A (https=) |
| CN (1) | CN116964207A (https=) |
| AU (1) | AU2021410086A1 (https=) |
| CA (1) | CA3206000A1 (https=) |
| MX (1) | MX2023007609A (https=) |
| WO (1) | WO2022140788A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023122062A1 (en) * | 2021-12-21 | 2023-06-29 | Cornell University | Methods for enhanced nucleic acid delivery |
| WO2024054901A1 (en) * | 2022-09-09 | 2024-03-14 | Spark Therapeutics, Inc. | Piperazine compounds |
| EP4583861A1 (en) * | 2022-09-09 | 2025-07-16 | Spark Therapeutics, Inc. | Enhancing non-viral dna delivery and expression |
| WO2025096940A1 (en) * | 2023-11-01 | 2025-05-08 | Spark Therapeutics, Inc. | Lipid compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140141065A1 (en) * | 2012-11-19 | 2014-05-22 | Discovery Genomics, Inc. | Method to achieve extended expression of dna infused into liver |
| WO2019018640A1 (en) * | 2017-07-21 | 2019-01-24 | Novartis Ag | POSOLOGICAL REGIMES FOR ANTI-GITREN ANTIBODIES AND USES THEREOF |
| WO2019226650A1 (en) * | 2018-05-23 | 2019-11-28 | Modernatx, Inc. | Delivery of dna |
| EP3934700A4 (en) * | 2019-03-06 | 2022-12-14 | Generation Bio Co. | NON-ACTIVE LIPID NANOPARTICLES WITH CAPSID-FREE, NON-VIRAL DNA |
-
2021
- 2021-12-22 WO PCT/US2021/073084 patent/WO2022140788A1/en not_active Ceased
- 2021-12-22 JP JP2023538718A patent/JP2024501284A/ja active Pending
- 2021-12-22 AU AU2021410086A patent/AU2021410086A1/en active Pending
- 2021-12-22 CN CN202180094347.5A patent/CN116964207A/zh active Pending
- 2021-12-22 CA CA3206000A patent/CA3206000A1/en active Pending
- 2021-12-22 EP EP21912293.4A patent/EP4267253A4/en active Pending
- 2021-12-22 US US18/258,981 patent/US20240074986A1/en active Pending
- 2021-12-22 MX MX2023007609A patent/MX2023007609A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024501284A5 (https=) | ||
| CA2163256C (fr) | Vecteurs adenoviraux d'origine animale et utilisation en therapie genique | |
| JP2011530599A5 (https=) | ||
| Templeton et al. | New directions in liposome gene delivery | |
| JP2022502055A5 (https=) | ||
| JP2021519099A5 (https=) | ||
| JP2022512578A5 (https=) | ||
| JP2000506865A (ja) | インターフェロンをコードする遺伝子の標的を定めた送達 | |
| JP2003519199A (ja) | 遺伝子治療のための新規なコロイド合成ベクター | |
| US20120058180A1 (en) | Liver-specific Nanocapsules and Methods of Using | |
| JP2022552371A5 (https=) | ||
| JP2006517581A5 (https=) | ||
| JPH07505773A (ja) | 標的化されたウイルスベクターを用いた遺伝子治療 | |
| TW201215394A (en) | Tetranectin-apolipoprotein A-I, lipid particles containing it and its use | |
| WO2014058179A2 (ko) | 저밀도 지단백질 유사 나노입자 및 이를 포함하는 간 표적 진단 및 치료용 조성물 | |
| JP2024540994A (ja) | 非ウイルス性ｄｎａ送達のための方法および組成物 | |
| JP2024506266A (ja) | 遺伝性血管性浮腫を治療するための組成物および方法 | |
| CN116964207A (zh) | 增强非病毒基因治疗的方法 | |
| JP2017503022A (ja) | インビボで細胞に活性型テロメラーゼを提供する組成物および方法 | |
| Martin Perez et al. | Enhancing the therapeutic potential of extracellular vesicles using peptide technology | |
| JP2024501022A5 (https=) | ||
| CN114569743B (zh) | 肝特异性的基因编辑纳米药物及其制备方法和应用 | |
| JP2026503551A (ja) | リピドイド化合物ならびに関連する組成物および使用 | |
| JP2003286189A (ja) | 中空ナノ粒子を形成するタンパク質に疾患治療用の細胞導入物質を融合させた薬剤 | |
| CN114452407A (zh) | 基因编辑递送系统及其制备方法和应用 |